Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Incontinence type
1.1.3. Usage
1.1.4. Distribution channel
1.1.5. End-use
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Incontinence type outlook
2.2.3. Usage outlook
2.2.4. Distribution channel outlook
2.2.5. End-use outlook
2.2.6. Regional outlook
2.3. Competitive Insights
Chapter 3. Male Urinary Incontinence Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of urinary incontinence (UI)
3.2.1.2. Growing geriatric population
3.2.1.3. Rapid technological advancements
3.2.1.4. Rise in demand for minimally invasive procedures
3.2.2. Market restraint analysis
3.2.2.1. Growing concerns regarding catheter associated urinary tract infection (CAUTI)
3.2.2.2. Availability of alternatives
3.3. Male Urinary Incontinence Market Analysis Tools
3.3.1. Industry Analysis – Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. COVID-19 Impact Analysis
Chapter 4. Male Urinary Incontinence Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Non-Absorbents
4.1.2. Absorbents
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global Male Urinary Incontinence Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
4.5.1. Non-Absorbents
4.5.1.1. Non-absorbents market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.1.1. Urinary Catheters
4.5.1.1.1.1. Urinary catheters market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.1.2. Foley Catheters
4.5.1.1.2.1. Foley catheters market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.1.3. External Catheters
4.5.1.1.3.1. External catheters market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.1.4. Drainage Bags
4.5.1.1.4.1. Drainage bags market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.1.5. External Compression Devices/Penile Clamps
4.5.1.1.5.1. External compression devices/penile clamps market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.1.6. Artificial Urinary Sphincter
4.5.1.1.6.1. Artificial urinary sphincter market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.1.7. Others
4.5.1.1.7.1. Others market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Absorbents
4.5.2.1. Absorbents market estimates and forecast 2018 to 2030s (USD Million)
4.5.2.1.1. Underwear & Briefs
4.5.2.1.1.1. Underwear & briefs market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.1.2. Drip Collectors & Bed Protectors
4.5.2.1.2.1. Drip collectors & bed protectors market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.1.3. Pads & Guards
4.5.2.1.3.1. Pads & guards market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Male Urinary Incontinence Market: Incontinence Type Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Stress Urinary Incontinence
5.1.2. Urge Urinary Incontinence
5.1.3. Overflow Incontinence
5.1.4. Functional Urinary Incontinence
5.1.5. Mixed Urinary Incontinence
5.2. Incontinence Type Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Global Male Urinary Incontinence Market by Incontinence Type Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
5.5.1. Stress Urinary Incontinence
5.5.1.1. Stress urinary incontinence market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Urge Urinary Incontinence
5.5.2.1. Urge urinary incontinence market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Overflow Incontinence
5.5.3.1. Overflow incontinence market estimates and forecast 2018 to 2030 (USD Million)
5.5.4. Functional Urinary Incontinence
5.5.4.1. Functional urinary incontinence market estimates and forecast 2018 to 2030 (USD Million
5.5.5. Mixed Urinary Incontinence
5.5.5.1. Mixed urinary incontinence market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Male Urinary Incontinence Market: Usage Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Reusable
6.1.2. Disposable
6.2. Usage Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. Global Male Urinary Incontinence Market by Usage Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Reusable
6.5.1.1. Reusable market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Disposable
6.5.2.1. Disposable market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Male Urinary Incontinence Market: Distribution Channel Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Offline Stores
7.1.2. Online Channels
7.2. Distribution Channel Market Share, 2018 & 2030
7.3. Segment Dashboard
7.4. Global Male Urinary Incontinence Market by Distribution Channel Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5.1. Offline Stores
7.5.1.1. Offline stores market estimates and forecast 2018 to 2030 (USD Million)
7.5.2. Online Channels
7.5.2.1. Online channels market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. Male Urinary Incontinence Market: End Use Estimates & Trend Analysis
8.1. Definitions and Scope
8.1.1. Hospitals & Clinics
8.1.2. Homecare
8.1.3. Others
8.2. End Use Market Share, 2018 & 2030
8.3. Segment Dashboard
8.4. Global Male Urinary Incontinence by End Use Outlook
8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5.1. Hospitals & Clinics
8.5.1.1. Hospitals & clinics market estimates and forecast 2018 to 2030 (USD Million)
8.5.2. Homecare
8.5.2.1. Homecare market estimates and forecast 2018 to 2030 (USD Million)
8.5.3. Others
8.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 9. Male Urinary Incontinence Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2018 & 2030
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Market Size, & Forecasts Trend Analysis, 2023 to 2030:
9.5. North America
9.5.1. U.S.
9.5.1.1. U.S. market estimates and forecast, 2018 – 2030 (USD Million)
9.5.2. Canada
9.5.2.1. Canada market estimates and forecast, 2018 – 2030 (USD Million)
9.6. Europe
9.6.1. UK
9.6.1.1. UK market estimates and forecast, 2018 – 2030 (USD Million)
9.6.2. Germany
9.6.2.1. Germany market estimates and forecast, 2018 – 2030 (USD Million)
9.6.3. France
9.6.3.1. France market estimates and forecast, 2018 – 2030 (USD Million)
9.6.4. Italy
9.6.4.1. Italy market estimates and forecast, 2018 – 2030 (USD Million)
9.6.5. Spain
9.6.5.1. Spain market estimates and forecast, 2018 – 2030 (USD Million)
9.6.6. Norway
9.6.6.1. Norway market estimates and forecast, 2018 – 2030 (USD Million)
9.6.7. Sweden
9.6.7.1. Sweden market estimates and forecast, 2018 – 2030 (USD Million)
9.6.8. Denmark
9.6.8.1. Denmark market estimates and forecast, 2018 – 2030 (USD Million)
9.7. Asia Pacific
9.7.1. Japan
9.7.1.1. Japan market estimates and forecast, 2018 – 2030 (USD Million)
9.7.2. China
9.7.2.1. China market estimates and forecast, 2018 – 2030 (USD Million)
9.7.3. India
9.7.3.1. India market estimates and forecast, 2018 – 2030 (USD Million)
9.7.4. Australia
9.7.4.1. Australia market estimates and forecast, 2018 – 2030 (USD Million)
9.7.5. South Korea
9.7.5.1. South Korea market estimates and forecast, 2018 – 2030 (USD Million)
9.7.6. Thailand
9.7.6.1. Thailand market estimates and forecast, 2018 – 2030 (USD Million)
9.8. Latin America
9.8.1. Brazil
9.8.1.1. Brazil market estimates and forecast, 2018 – 2030 (USD Million)
9.8.2. Mexico
9.8.2.1. Mexico market estimates and forecast, 2018 – 2030 (USD Million)
9.8.3. Argentina
9.8.3.1. Argentina market estimates and forecast, 2018 – 2030 (USD Million)
9.9. MEA
9.9.1. South Africa
9.9.1.1. South Africa market estimates and forecast, 2018 – 2030 (USD Million)
9.9.2. Saudi Arabia
9.9.2.1. Saudi Arabia market estimates and forecast, 2018 – 2030 (USD Million)
9.9.3. UAE
9.9.3.1. UAE market estimates and forecast, 2018 – 2030 (USD Million)
9.9.4. Kuwait
9.9.4.1. Kuwait market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.2.1. Innovators
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.3.3. Key company market share analysis, 2022
10.3.4. Essity
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Usage benchmarking
10.3.4.4. Strategic initiatives
10.3.5. Boston Scientific Corporation
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Usage benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Kimberly-Clark Worldwide Inc.
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Usage benchmarking
10.3.6.4. Strategic initiatives
10.3.7. Attends Healthcare Products, Inc.
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Usage benchmarking
10.3.7.4. Strategic initiatives
10.3.8. ABENA
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Usage benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Ontex Healthcare
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Usage benchmarking
10.3.9.4. Strategic initiatives
10.3.10. PAUL HARTMANN AG
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Usage benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Teleflex Incorporated
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Usage benchmarking
10.3.11.4. Strategic initiatives
10.3.12. First Quality
10.3.12.1. Company overview
10.3.12.2. Financial performance
10.3.12.3. Usage benchmarking
10.3.12.4. Strategic initiatives
10.3.13. Coloplast Corp.
10.3.13.1. Company overview
10.3.13.2. Financial performance
10.3.13.3. Usage benchmarking
10.3.13.4. Strategic initiatives
10.3.14. Medline
10.3.14.1. Company overview
10.3.14.2. Financial performance
10.3.14.3. Usage benchmarking
10.3.14.4. Strategic initiatives
10.3.15. BD
10.3.15.1. Company overview
10.3.15.2. Financial performance
10.3.15.3. Usage benchmarking
10.3.15.4. Strategic initiatives
10.3.16. Hollister Incorporated
10.3.16.1. Company overview
10.3.16.2. Financial performance
10.3.16.3. Usage benchmarking
10.3.16.4. Strategic initiatives
10.3.17. Cardinal Health
10.3.17.1. Company overview
10.3.17.2. Financial performance
10.3.17.3. Usage benchmarking
10.3.17.4. Strategic initiatives
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/